Eraxis package insert
WebJan 1, 2008 · Fungal infections are a significant cause of morbidity and mortality in immunocompromised children. Since the beginning of the 21st century, many new antifungals including the echinocandins (i.e., caspofungin, micafungin, anidulafungin) and the newer generation triazoles (i.e., voriconazole and posaconazole) have received Food … WebOct 8, 2024 · 9. Pfizer Inc. Eraxis [package insert]. New York, NY: Pfizer Inc., 2006. 10. Keirns J, Sawamoto T, Holum M, Buell D, Wisemandale W, Alak A. Steady-state phar-macokinetics of micafungin and voriconaz-ole after separate and concomitant dosing in healthy adults. Antimicrob Agents Chemother, 2007;51:787–790. 11. Stover KR, Cleary …
Eraxis package insert
Did you know?
WebFeb 12, 2024 · ERAXIS (Page 5 of 7) Roerig 12 February 2024. 12.4 Microbiology. Mechanism of Action. Anidulafungin is a semi-synthetic echinocandin with antifungal activity. Anidulafungin inhibits glucan synthase, an enzyme present in fungal, but not mammalian cells. This results in inhibition of the formation of 1,3-β-D-glucan, an essential component … WebOct 12, 2024 · sore or white patches in your mouth or throat; low blood pressure, feeling light-headed; anemia, bruising or bleeding, nosebleed; fever; stomach pain, indigestion, nausea, vomiting, diarrhea; low potassium; headache, trouble sleeping; or. rash. This is not a complete list of side effects and others may occur.
WebAnidulafungin 50mg/vial, 100mg/vial; lyophilized pwd for IV infusion after reconstitution and dilution; preservative-free; contains fructose, mannitol, polysorbate 80. WebThe safety and efficacy of ERAXIS have not been established in neonates (<1 month old) (see section 4.4). Method of administration For intravenous use only. ERAXIS should be …
WebNov 5, 2015 · Itraconazole package labeling now includes a warning against use in patients with a history of heart failure. In a more recent, similarly designed study, the FAERS system query from 2004 to 2012 contained 3 419 016 records, including several echinocandin (n = 11 761) and azole (n = 184 843) antifungal adverse events. WebSep 3, 2024 · See PACKAGE INSERT for PATIENT COUNSELING INFORMATION and Medication Guide. DOSAGE AND ADMINISTRATION 2.1 Recommended Dosage . The recommended dosage of AVYCAZ is 2.5 grams (ceftazidime 2 grams and avibactam 0.5 grams) administered every 8 hours by intravenous (IV) infusion over 2 hours in patients …
WebFeb 12, 2024 · ERAXIS for Injection is a sterile, lyophilized product for intravenous (IV) infusion that contains anidulafungin. ERAXIS (anidulafungin) is a semi-synthetic lipopeptide synthesized from a fermentation product of Aspergillus nidulans. Anidulafungin is an echinocandin, a class of antifungal drugs that inhibits the synthesis of 1,3-β-D-glucan, an ...
WebSep 4, 2007 · The echinocandins are a new class of lipopeptide antifungal agents that act by inhibiting the synthesis of (1,3)-β- d -glucan. Compounds of this class are relatively highly protein bound, with rates of 96% reported for caspofungin ( 5 ), 99.8% for micafungin ( 15 ), and ~99% for anidulafungin (Eraxis package insert; Pfizer). dan bernard king countyWeb3 rows · Feb 17, 2006 · Eraxis Prescribing Information. Package insert / product label Generic name: anidulafungin ... birds in treeWebERAXIS® Quick Finder Pfizer samples (for eligible HCPs) Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800 … dan bernath deathWebNov 30, 2024 · Eraxis is an antifungal medication that fights infections caused by fungus. Eraxis is used to treat candida (yeast) infections in the blood or the stomach in adults … dan bernard total computerWebApr 16, 2010 · Introduction Systemic fungal infection most commonly occurs in the setting of compromise of the immune system. Severe immune compromise often results from an attempt to treat disease. This pharmacologically induced immune compromise must be carefully controlled to prevent untoward outcomes. birds in vent on side of houseWebFinal Approved Package Insert–20 March 2024 Page 3of 23 Distribution Plasma protein binding in humans is approximately 87 %.The volume of distribution (Vss) is approximately 21 litres. Metabolism and elimination Apixaban has multiple routes of elimination. Of the administered apixaban dose in humans, birds in watercolor collage and inkdan bernhardt economics